Stocks
Chembio Diagnostics, Inc.CEMI
NASDAQHealthcareDiagnostics & Research$0.46+0.22%
Developer of rapid diagnostic tests used to detect infectious diseases at the point of care, primarily through its Dual Path Platform (DPP) lateral flow technology. The company’s products have targeted conditions such as HIV, COVID‑19, and other global health threats, with customers that have includ...
Market Cap: $16.7M52W Range: $0.19 – $1.24
Congressional Interest in Chembio Diagnostics, Inc. (CEMI)
1 member of Congress has disclosed 2 trades in Chembio Diagnostics, Inc. (CEMI), a Healthcare company. The buy/sell breakdown shows 0 purchases versus 2 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
2
Unique Politicians
1
Buys
0
Sells
2
Who in Congress Is Trading CEMI?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2020-03-24 | Tom Malinowski | sell | $1K – $15K |
| 2020-03-19 | Tom Malinowski | sell | $1K – $15K |